Nitrazepam Lph

Nitrazepam, the active ingredient in Nitrazepam Lph, is a benzodiazepine presented as a tablet for oral use. It treats insomnia, severe anxiety, and seizure disorders in adult patients.

GNH USA supplies Nitrazepam Lph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrazepam is a benzodiazepine that acts on the central nervous system to manage several neurological and psychiatric conditions. - Insomnia: helps initiate and maintain sleep in patients with difficulty falling or staying asleep. - Severe anxiety: reduces excessive worry and tension when other anxiolytics are insufficient. - Seizure disorders: provides adjunctive control of certain types of seizures, especially when rapid onset of action is needed.

Nitrazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Dizziness: sensation of light‑headedness or loss of balance. - Impaired coordination: reduced motor control affecting tasks such as driving. - Memory impairment: difficulty recalling recent events. - Headache: mild to moderate pain in the head region. - Fatigue: persistent lack of energy.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that may require medical attention. - Paradoxical agitation: increased anxiety, aggression, or hostility. - Dependence or addiction: development of physical or psychological reliance on the drug. - Suicidal thoughts: emergence of self‑harm ideation. - Severe skin reactions: rash, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. - Hypotension: marked drop in blood pressure leading to faintness.

Before prescribing Nitrazepam, clinicians should consider several safety measures. - Assess renal and hepatic function: adjust use if impairment is present. - Review patient history for substance abuse: avoid in individuals with dependence risk. - Monitor for depression or suicidal ideation: discontinue if worsening occurs. - Caution in elderly patients: increased sensitivity to sedation and falls. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture and light.

Nitrazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other central nervous system depressants (e.g., opioids, barbiturates): may cause profound sedation or respiratory depression. - Alcohol: synergistic depressant effect increasing risk of accidents. - Antiepileptic drugs that induce hepatic enzymes (e.g., carbamazepine): may reduce nitrazepam levels.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants: may enhance sedation. - Antihistamines: can increase drowsiness and impair cognition.